OrganizationsAmunix

Products 1 to 1 of 1

Biotech components: Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (9 months ago)
Date last modified: 2020/12/18 14:40 (9 months ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input